TITLE

LONG-TERM ANTICOAGULANT THERAPY IN THE TREATMENT OF INTERMITTENT CLAUDICATION

AUTHOR(S)
Milnés-López, Bernardo; Carrillo, Pedro; Toledo, Fernando; McCook, George
PUB. DATE
December 1957
SOURCE
Angiology;Dec1957, Vol. 8 Issue 6, p534
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the long-term anticoagulant therapy in the treatment of intermittent claudication. Evaluation of intermittent claudication; Effect of long continued anticoagulant therapy on intermittent claudication; Degree of improvement of the treatment.
ACCESSION #
16351420

 

Related Articles

  • Multicenter Double--Blind Study of Ticlopidine in the Treatment of Intermittent Claudication and the Prevention of its Complications. Arcan, J. C.; Blanchard, J.; Boissel, J. P.; Destors, J. M.; Panak, E. // Angiology;Sep1988, Vol. 39 Issue 9, p802 

    In this multicenter trial 169 patients with chronic intermittent claudication due to obstructive peripheral vascular disease were randomized in a double-blind fashion into two parallel groups receiving either 250 mg ticlopidine or placebo, twice daily. At entry, the two groups (83 ticlopidine,...

  • INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S. // Angiology;Aug1958, Vol. 9 Issue 4, p245 

    Provides information about intermittent claudication. Cause and pathogenesis; Signs and symptoms; Diagnosis and treatment;

  • The low down on claudicant leg pain. Targett, Steve // New Zealand Doctor;6/14/2006, p34 

    Presents information on claudicant leg pain. Description of the leg pain; Causes; Treatment.

  • A Botanical Compound, Padma 28, Increases Walking Distance in Stable Intermittent Claudication. Drabaek, Hans; Mehlsen, Jesper; Himmelstrup, Holger; Winther, Kaj // Angiology;Nov1993, Vol. 44 Issue 11, p863 

    Thirty-six patients with a median age of sixty-seven years and a median duration of intermittent claudication of five years were randomized to either active treatment with Padma 28 or placebo. The effect of treatment was quantified by measurements of systemic and peripheral systolic blood...

  • NEW CLINICAL APPROACH TO THE MANAGEMENT OF INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S.; Shaftel, Herbert E. // Angiology;Dec1958, Vol. 9 Issue 6, p378 

    Examines a clinical approach to the management of intermittent claudication or angina cruris. Consideration of plethysmographic studies in judging the effect of vasodilating drugs on the peripheral circulation; Importance of supplementing vasodilators with tranquilizers; Description of the...

  • Randomized Reliability Study Evaluating Constant-load and Graded-exercise Treadmill Test for Intermittent Claudication. Cachovan, Milan; Rogatti, Waltraud; Woltering, Franz; Creutzig, Andreas; Diehm, Curt; Heidrich, Heinz; Scheffler, Peter // Angiology;Mar1999, Vol. 50 Issue 3, p193 

    The aim of this randomized study was to compare the reliability of the treadmill test at constant-load (C-test, 3 km/hr; fixed grade of 12%) recommended in Germany with that of the graded-exercise test (G-test, 3 km/hr; increase in grade of 3.5% every 3 minutes) propagated in the United States....

  • Treatment of intermittent claudication. Karthikeyan, G.; Eikelboom, John W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p671 

    The authors reflect on methods which are used to treat intermittent claudication. They suggest that any methods that are used should improve the patient's symptoms and decrease the risk of cardiovascular problems. They argue that the most important goal of medical treatment in patients with...

  • The prognostic impact of general and abdominal obesity in peripheral arterial disease. Giugliano, G.; Brevetti, G.; Laurenzano, E.; Brevetti, L.; Luciano, R.; Chiariello, M. // International Journal of Obesity;Feb2010, Vol. 34 Issue 2, p280 

    Objective:Obesity is an independent cardiovascular risk factor, but its prognostic role in patients with peripheral arterial disease (PAD) is not well defined. Accordingly, we assessed the impact of body mass index (BMI) and waist circumference (WC) on cardiovascular risk in a homogeneous cohort...

  • New developments in intermittent claudication. Stansby, Gerard // Pulse;4/30/2005, Vol. 65 Issue 17, p57 

    The article cites new developments in intermittent claudication (IC). Background IC is often the first symptom of peripheral arterial disease and is usually due to widespread atherosclerosis. However, IC symptoms often go unreported by patients since they assume the cramp-like pain on walking to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics